ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases

ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases

Rodica Ungur,1,2 Adrian Tempescul,3 Christian Berthou,3 Cristina Bagacean,1,2 Doinel Radeanu,1 Adriana Muresan,1 Mihnea Zdrenghea1,21Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj, 2Department of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania;...

Full description

Bibliographic Details
Main Authors: Ungur R, Tempescul A, Berthou C, Bagacean C, Radeanu D, Muresan A, Zdrenghea M
Format: Article
Language:English
Published: Dove Medical Press 2015-10-01
Series:OncoTargets and Therapy
Online Access:https://www.dovepress.com/eshap-chemotherapy-is-efficient-in-refractoryrelapsed-primary-central--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/eshap-chemotherapy-is-efficient-in-refractoryrelapsed-primary-central--peer-reviewed-article-OTT

Similar Items